Monitoring xenotransplant recipients for infection by PERV

C Herring1, D A Cunningham, A J Whittam

  • 1Porcine Endogenous Retrovirus Research Group, Imutran Ltd (A Novartis Pharma AG Co), PO Box 399, CB2 2YP, Cambridge, UK. Chris.herring@pharma.novartis.com

Clinical Biochemistry
|March 10, 2001
PubMed
Abstract